Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;33(2):53-64.
doi: 10.1016/j.urolonc.2014.06.013. Epub 2014 Jul 25.

Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward

Andrea B Apolo  1 , Vanessa Hoffman  2 , Matthew G Kaag  3 , David M Latini  4 , Cheryl T Lee  5 , Jonathan E Rosenberg  6 , Margaret Knowles  7 , Dan Theodorescu  8 , Bogdan A Czerniak  9 , Jason A Efstathiou  10 , Matthew L Albert  11 , Srikala S Sridhar  12 , Vitaly Margulis  13 , Surena F Matin  14 , Matthew D Galsky  15 , Donna Hansel  16 , Ashish M Kamat  14 , Thomas W Flaig  8 , Angela B Smith  17 , Edward Messing  18 , Diane Zipursky Quale  2 , Yair Lotan  19
Affiliations
Review

Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward

Andrea B Apolo et al. Urol Oncol. 2015 Feb.

Abstract

Objectives: The 8th Annual Bladder Cancer Think Tank (BCAN-TT) brought together a multidisciplinary group of clinicians, researchers, and patient advocates in an effort to advance bladder cancer research.

Methods and materials: With the theme of "Collaborating to Move Research Forward," the meeting included three panel presentations and seven small working groups.

Results: The panel presentations and interactive discussions focused on three main areas: gender disparities, sexual dysfunction, and targeting novel pathways in bladder cancer. Small working groups also met to identify projects for the upcoming year, including: (1) improving enrollment and quality of clinical trials; (2) collecting data from multiple institutions for future research; (3) evaluating patterns of care for non-muscle-invasive bladder cancer; (4) improving delivery of care for muscle-invasive disease; (5) improving quality of life for survivors; (6) addressing upper tract disease; and (7) examining the impact of health policy changes on research and treatment of bladder cancer.

Conclusions: The goal of the BCAN-TT is to advance the care of patients with bladder cancer and to promote collaborative research throughout the year. The meeting provided ample opportunities for collaboration among clinicians from multiple disciplines, patients and patient advocates, and industry representatives.

Keywords: BCAN; Bladder cancer; Gender disparities; Sexual dysfunction; Targeted therapies; Think Tank; Working groups.

PubMed Disclaimer

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11–30. - PubMed
    1. Brown T, Slack R, Rushton L. Occupational cancer in Britain. Urinary tract cancers: bladder and kidney. Br J Cancer 2012;107 (Suppl. 1):S76–84. - PMC - PubMed
    1. Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63:234–41. - PubMed
    1. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. J Am Med Assoc 2011;306:737–45. - PMC - PubMed
    1. Hartge P, Harvey EB, Linehan WM, et al. Unexplained excess risk of bladder cancer in men. J Natl Cancer Inst 1990;82:1636–40. - PubMed